Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Real-World Validation of the European Leukemia Network 2022 Risk Stratification in Acute Myelogenous Leukemia

Sarah Elizabeth Mudra, Paul Sackstein, Lacey Scott Williams, Garrett Diltz, Rachel Zemel, Ashwin Kumar, Purnima Sravanti Teegavarapu, Martha P. Mims, Catherine Lai, Kimberley Doucette, Gustavo A. Rivero

Blood (2023) 142 (Supplement 1): 4297.

https://doi.org/10.1182/blood-2023-189309

Published: 2023

Journal Articles

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Jun Yang Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Ouyomi, Omar Rosales, Raka Bandyo, Akiva Diamond, Gustavo A. Rivero, Courtney Nicole Miller-Chism, Mark M. Udden, Martha P. Mims, Christopher R. Flowers, Ang Li, Purnima Sravanti Teegavarapu

Blood (2023) 142 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2023-173927

Published: 2023

Journal Articles

Disparities Among Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia

Elyse Lopez, Deepa Dongarwar, Martha P. Mims, Sara Taveras Alam

Blood (2023) 142 (Supplement 1): 5169.

https://doi.org/10.1182/blood-2023-190913

Published: 2023

Journal Articles

Investigating Racially Induced Metabolic and Genomic Signatures Mediating Inferior Survival in African Americans with Acute Myelogenous Leukemia

Lacey Scott Williams, Alexis K Williams, Sarah Elizabeth Mudra, Paul Sackstein, Garrett Diltz, Rachel Zemel, Purnima Sravanti Teegavarapu, Martha P. Mims, Kimberley Doucette, Catherine Lai, Gustavo A. Rivero

Blood (2023) 142 (Supplement 1): 4320.

https://doi.org/10.1182/blood-2023-190898

Published: 2023

Journal Articles

Specific Nucleotide Substitutions and Stressors Erode Highly Conserved Genomic Regions in Acute Myelogenous Leukemia

Nikhil Patel, Gustavo Rivero, Martha P. Mims, Purnima Sravanti Teegavarapu, Gianfranco Bittar, Diana De Oliviera

Blood (2022) 140 (Supplement 1): 6112–6113.

https://doi.org/10.1182/blood-2022-171086

Published: 2022

Journal Articles

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Brandon J Kale, Grace Hwang, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Blood (2022) 140 (Supplement 1): 8934–8935.

https://doi.org/10.1182/blood-2022-170210

Published: 2022

Journal Articles

Predictors of Inferior Survival in African American Patients with Diffuse Large B-Cell Lymphoma

Kevin Tang, Heidi M Krause, Nikhil Patel, Grace Hwang, Jason Lu, Martha P. Mims, Mark M. Udden, Courtney Nicole Miller-Chism, Gustavo Rivero, Purnima Sravanti Teegavarapu

Blood (2022) 140 (Supplement 1): 8101–8102.

https://doi.org/10.1182/blood-2022-168224

Published: 2022

Journal Articles

Tobacco Use Predicts Unique Mutagenesis Signature in Acute Myelogenous Leukemia

Tran Hoang, Gianfranco Bittar, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Blood (2021) 138 (Supplement 1): 1297.

https://doi.org/10.1182/blood-2021-154173

Published: 2021

Journal Articles

Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

Sara Taveras Alam, Deepa Dongarwar, Elyse Lopez, Sarvari Venkata Yellapragada, Gustavo Rivero, Courtney Nicole Miller-Chism, Martha P. Mims, Quillan Huang, Hamisu Salihu

Blood (2021) 138 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2021-153029

Published: 2021

Journal Articles

Obesity Is Associated with Increased Relapse Risk in Diffuse Large B-Cell Lymphoma

Kevin Tang, Jorge Mazzini, Martha P. Mims, Gustavo Rivero, Purnima Sravanti Teegavarapu

Blood (2021) 138 (Supplement 1): 1449.

https://doi.org/10.1182/blood-2021-154153

Published: 2021

Journal Articles

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Anjali S. Advani, MD, Anna Moseley, M.S., Michaela Liedtke, MD, Margaret R O'Donnell, MD, Ibrahim Aldoss, MD, Martha P. Mims, MD PhD, Kristen Marie O'Dwyer, MD, Megan Othus, PhD, Harry P. Erba, MD PhD

Blood (2019) 134 (Supplement_1): 227.

https://doi.org/10.1182/blood-2019-125340

Published: 2019

Journal Articles

Safety Analysis of Two Randomized Controlled Studies of Venetoclax in Patients with Chronic Lymphocytic Leukemia

Samer Al Hadidi, MDMSc, Rammurti Kamble, MD, Courtney Nicole Miller-Chism, MD, Martha P. Mims, MD PhD

Blood (2019) 134 (Supplement_1): 5472.

https://doi.org/10.1182/blood-2019-126353

Published: 2019

Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 2678.

https://doi.org/10.1182/blood-2019-129183

Published: 2019

Journal Articles

Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple Myeloma

Samer Al Hadidi, MDMSc, Rammurti Kamble, MD, Courtney Nicole Miller-Chism, MD, Martha P. Mims, MD PhD

Blood (2019) 134 (Supplement_1): 3175.

https://doi.org/10.1182/blood-2019-126341

Published: 2019

Journal Articles

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Rafee Talukder, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 1438.

https://doi.org/10.1182/blood-2019-131581

Published: 2019

Journal Articles

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Anjali S. Advani, MD, Anna Moseley, Michaela Liedtke, MD, Margaret O'Donnell, MD, Megan Othus, PhD, Martha P. Mims, MD PhD, Kristen O'Dwyer, MD, Harry P. Erba, MD PhD

Blood (2016) 128 (22): 1634.

https://doi.org/10.1182/blood.V128.22.1634.1634

Published: 2016

Journal Articles

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Claudia Rodriguez, MD,, Alcedo Pedro, Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2016) 128 (22): 5537.

https://doi.org/10.1182/blood.V128.22.5537.5537

Published: 2016

Journal Articles

Cigarette Smoking Is Associated with Adverse Outcome in Low Risk MDS Patients

Effie Rahman, Sarvari Venkata Yellapragada, Martha P. Mims, Kirtan Nautiyal, MD, Manuel Molina, MD, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5628.

https://doi.org/10.1182/blood.V124.21.5628.5628

Published: 2014

Journal Articles

High Frequency of Identical Lymphoma Clones Detected in Pre-Treatment Tumor and Plasma from Untreated Patients with HIV-Associated Lymphomas: Prospective Multicenter Trial of the AIDS Malignancy Consortium (AMC 064)

Nina Wagner-Johnston, Jeannette Y. Lee, Sylvia Silver, Ariela Noy, Martha P. Mims, Francois Pepin, Martin Moorhead, PhD, Malek Faham, Richard F. Ambinder

Blood (2014) 124 (21): 1680.

https://doi.org/10.1182/blood.V124.21.1680.1680

Published: 2014

Journal Articles

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Gabriela Sanchez, MD, Ang Li, MD, Sarvari Venkata Yellapragada, MD, Martha P. Mims, Anna Frolov, Effie Rahman, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5621.

https://doi.org/10.1182/blood.V124.21.5621.5621

Published: 2014

NARROW

Real-World Validation of the European Leukemia Network 2022 Risk Stratification in Acute Myelogenous Leukemia

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Disparities Among Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia

Investigating Racially Induced Metabolic and Genomic Signatures Mediating Inferior Survival in African Americans with Acute Myelogenous Leukemia

Specific Nucleotide Substitutions and Stressors Erode Highly Conserved Genomic Regions in Acute Myelogenous Leukemia

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Predictors of Inferior Survival in African American Patients with Diffuse Large B-Cell Lymphoma

Tobacco Use Predicts Unique Mutagenesis Signature in Acute Myelogenous Leukemia

Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

Obesity Is Associated with Increased Relapse Risk in Diffuse Large B-Cell Lymphoma

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Safety Analysis of Two Randomized Controlled Studies of Venetoclax in Patients with Chronic Lymphocytic Leukemia

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple Myeloma

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Cigarette Smoking Is Associated with Adverse Outcome in Low Risk MDS Patients

High Frequency of Identical Lymphoma Clones Detected in Pre-Treatment Tumor and Plasma from Untreated Patients with HIV-Associated Lymphomas: Prospective Multicenter Trial of the AIDS Malignancy Consortium (AMC 064)

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only